| Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD F Lavorini, A Magnan, JC Dubus, T Voshaar, L Corbetta, M Broeders, ... Respiratory medicine 102 (4), 593-604, 2008 | 829 | 2008 |
| Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind … GL Chupp, ES Bradford, FC Albers, DJ Bratton, J Wang-Jairaj, LM Nelsen, ... The Lancet Respiratory Medicine 5 (5), 390-400, 2017 | 551 | 2017 |
| The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team GK Crompton, PJ Barnes, M Broeders, C Corrigan, L Corbetta, ... Respiratory medicine 100 (9), 1479-1494, 2006 | 400 | 2006 |
| Importance of inhaler devices in the management of airway disease JC Virchow, GK Crompton, R Dal Negro, S Pedersen, A Magnan, ... Respiratory medicine 102 (1), 10-19, 2008 | 399 | 2008 |
| IL-17 in severe asthma. Where do we stand? J Chesné, F Braza, G Mahay, S Brouard, M Aronica, A Magnan American journal of respiratory and critical care medicine 190 (10), 1094-1101, 2014 | 392 | 2014 |
| Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients M Humbert, G Monti, M Fartoukh, A Magnan, F Brenot, B Rain, F Capron, ... European Respiratory Journal 11 (3), 554-559, 1998 | 380 | 1998 |
| Allergic vs nonallergic asthma: what makes the difference? S Romanet‐Manent, D Charpin, A Magnan, A Lanteaume, D Vervloet, ... Allergy 57 (7), 607-613, 2002 | 352 | 2002 |
| Assessment of the Th1/Th2 Paradigm in Whole Blood in Atopy and Asthma: Increased IFN- γ –producing CD8+ T Cells in Asthma AO Magnan, LG Mely, CA Camilla, MM Badier, FA Montero-Julian, ... American journal of respiratory and critical care medicine 161 (6), 1790-1796, 2000 | 340 | 2000 |
| MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ... Allergy 70 (11), 1372-1392, 2015 | 307 | 2015 |
| A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma G Garcia, A Magnan, R Chiron, C Contin-Bordes, P Berger, C Taillé, ... Chest 144 (2), 411-419, 2013 | 243 | 2013 |
| Research needs in allergy: an EAACI position paper, in collaboration with EFA NG Papadopoulos, I Agache, S Bavbek, BM Bilo, F Braido, V Cardona, ... Clinical and translational allergy 2, 1-23, 2012 | 235 | 2012 |
| ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ... Clinical and translational allergy 6 (1), 47, 2016 | 234 | 2016 |
| Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype M Pain, O Bermudez, P Lacoste, PJ Royer, K Botturi, A Tissot, S Brouard, ... European Respiratory Review 23 (131), 118-130, 2014 | 223 | 2014 |
| MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis J Bousquet, HJ Schünemann, PW Hellings, S Arnavielhe, C Bachert, ... Journal of Allergy and Clinical Immunology 138 (2), 367-374. e2, 2016 | 218 | 2016 |
| Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis–a EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement PW Hellings, WJ Fokkens, C Bachert, CA Akdis, T Bieber, I Agache, ... Allergy 72 (9), 1297-1305, 2017 | 190 | 2017 |
| Mesenchymal stem cells induce suppressive macrophages through phagocytosis in a mouse model of asthma F Braza, S Dirou, V Forest, V Sauzeau, D Hassoun, J Chesné, ... Stem Cells 34 (7), 1836-1845, 2016 | 171 | 2016 |
| Compliance, observance ou adhésion thérapeutique: de quoi parlons-nous? A Lamouroux, A Magnan, D Vervloet Revue des maladies respiratoires 22 (1), 31-34, 2005 | 169 | 2005 |
| MASK 2017: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma multimorbidity using real‐world‐evidence J Bousquet, S Arnavielhe, A Bedbrook, M Bewick, D Laune, ... Clinical and translational allergy 8 (1), 45, 2018 | 167 | 2018 |
| Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology J Bousquet, PW Hellings, I Agache, F Amat, I Annesi-Maesano, ... Journal of Allergy and Clinical Immunology 143 (3), 864-879, 2019 | 165 | 2019 |
| Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 164 | 2020 |
